Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

Fayers, Peter; Palumbo, Antonio; Hulin, Cyrille; Waage, Anders; W. Wijermans, Pierre; Beksaç, Meral; Bringhen, Sara; Mary, Jean‐Yves; Gimsing, Peter; Termorshuizen, Fabian; Haznedar, Rauf; Caravita, Tommaso; Moreau, Philippe; Turesson, Ingemar; Musto, Pellegrino; Benboubker, Lotfi; Ronald Schaafsma, M.; Sonneveld, Pieter; Façon, Thierry; behalf of the Nordic Myeloma Study Group, Italian Multiple Myeloma Network, Turkish Myeloma Study Group, Hemato-Oncologie voor Volwassenen Nederland, Intergroupe Francophone du Myélome, and European Myeloma Network, on

doi:10.1182/blood-2011-03-341669

Public

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

Published in Blood • Jun 14, 2011

Authors:

Peter Fayers

Antonio Palumbo

Cyrille Hulin

Abstract

The role of thalidomide for previously untreated elderly patients with multiple myeloma remains unclear. Six randomized controlled trials, launched in or after 2000, compared melphalan and prednisone alone (MP) and with thalidomide (MPT). The effect on overall survival (OS) varied across trials. We ...

Subject

Thalidomide

Hazard ratio

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!